BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23437135)

  • 21. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
    Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
    PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis.
    Wettstein C; Mugglin C; Egger M; Blaser N; Vizcaya LS; Estill J; Bender N; Davies MA; Wandeler G; Keiser O;
    AIDS; 2012 Nov; 26(18):2361-73. PubMed ID: 22948267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study.
    Maskew M; Bor J; MacLeod W; Carmona S; Sherman GG; Fox MP
    Lancet HIV; 2019 Nov; 6(11):e760-e768. PubMed ID: 31585836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa.
    Bärnighausen T; Tanser F; Malaza A; Herbst K; Newell ML
    Trop Med Int Health; 2012 Aug; 17(8):e103-10. PubMed ID: 22943374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.
    Koenig SP; Bernard D; Dévieux JG; Atwood S; McNairy ML; Severe P; Marcelin A; Julma P; Apollon A; Pape JW
    PLoS One; 2016; 11(2):e0146903. PubMed ID: 26901795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature.
    Plazy M; Orne-Gliemann J; Dabis F; Dray-Spira R
    BMJ Open; 2015 Jun; 5(6):e006927. PubMed ID: 26109110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unique features of pediatric HIV-1 in sub-Saharan Africa.
    De Baets AJ; Ramet J; Msellati P; Lepage P
    Curr HIV Res; 2008 Jun; 6(4):351-62. PubMed ID: 18691033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.
    Amanyire G; Semitala FC; Namusobya J; Katuramu R; Kampiire L; Wallenta J; Charlebois E; Camlin C; Kahn J; Chang W; Glidden D; Kamya M; Havlir D; Geng E
    Lancet HIV; 2016 Nov; 3(11):e539-e548. PubMed ID: 27658873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proportion of loss to follow-up from antiretroviral therapy (ART) and its association with age among adolescents living with HIV in sub-Saharan Africa: A systematic review and meta-analysis.
    Leshargie CT; Demant D; Burrowes S; Frawley J
    PLoS One; 2022; 17(8):e0272906. PubMed ID: 35951621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Providing immediate CD4 count results at HIV testing improves ART initiation.
    Faal M; Naidoo N; Glencross DK; Venter WD; Osih R
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e54-9. PubMed ID: 21857356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
    Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.
    Collins IJ; Cairns J; Jourdain G; Fregonese F; Nantarukchaikul M; Lertpienthum N; Wannarit P; Attavinijtrakarn P; Layangool P; Le Coeur S; Lallemant M;
    AIDS; 2012 Sep; 26(15):1943-52. PubMed ID: 22824633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.